LPCN

2.33

1.75% 0.04

Vorhandelsmarkt: 2.32 -0.01 -0.43%

Lipocine Inc (LPCN)

Überblick Nachrichten Preisverlauf Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.29

Offen:

$2.3

24-Stunden-Volumen:

94,791

Relative Volume:

0.25

Marktkapitalisierung:

$18.70M

Einnahmen:

$1.98M

Nettoeinkommen (Verlust:

$-9.63M

KGV:

-1.3199

EPS:

-1.7653

Netto-Cashflow:

$-9.76M

1W Leistung:

+0.87%

1M Leistung:

+13.66%

6M Leistung:

-8.98%

1J Leistung:

-31.87%

1-Tages-Spanne:

$2.26

$2.35

1-Wochen-Bereich:

$2.2001

$2.39

52-Wochen-Spanne:

$1.81

$12.37

Lipocine Inc Stock (LPCN) Company Profile

Firmenname

Lipocine Inc

Sektor

Healthcare (1106)

Branche

Biotechnology (615)

Telefon

801 994 7383

Adresse

675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT

Mitarbeiter

Twitter

Nächster Verdiensttermin

2026-05-14

Neueste SEC-Einreichungen

LPCN's Discussions on Twitter

Compare LPCN vs VRTX, REGN, ARGX, ALNY, ONC

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
LPCN Lipocine Inc	2.33	18.70M	1.98M	-9.63M	-9.76M	-1.7653
VRTX Vertex Pharmaceuticals Inc	424.36	107.87B	12.32B	4.34B	3.19B	16.86
REGN Regeneron Pharmaceuticals Inc	702.27	73.63B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	794.70	49.42B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	301.11	40.20B	3.71B	313.75M	465.38M	2.2571
ONC Beone Medicines Ltd Adr	297.49	33.06B	5.36B	287.73M	924.18M	2.5229

Lipocine Inc Stock (LPCN) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2026-04-06	Herabstufung	H.C. Wainwright	Buy → Neutral
2021-06-24	Eingeleitet	Cantor Fitzgerald	Overweight
2020-12-10	Hochstufung	Ladenburg Thalmann	Neutral → Buy
2018-01-12	Bestätigt	H.C. Wainwright	Buy
2018-01-11	Herabstufung	Canaccord Genuity	Buy → Hold
2017-12-08	Fortgesetzt	H.C. Wainwright	Buy
2016-10-07	Eingeleitet	H.C. Wainwright	Buy
2015-07-22	Eingeleitet	ROTH Capital	Buy
2015-06-23	Eingeleitet	Canaccord Genuity	Buy

Alle ansehen

Lipocine Inc Aktie (LPCN) Neueste Nachrichten

May 05, 2026

MSN Money - MSN

May 05, 2026

May 04, 2026

Lipocine Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

May 04, 2026

Apr 30, 2026

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session - Quantisnow

Apr 28, 2026

Apr 26, 2026

Lipocine (LPCN) price target decreased by 15.38% to 11.22 - MSN

Apr 26, 2026

Apr 22, 2026

LPCN (Lipocine Inc.) posts narrower Q4 2025 loss than analyst estimates, shares rise modestly in trading today.Put/Call Ratio - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 22, 2026

Apr 21, 2026

Lipocine (LPCN) 2026 proxy seeks director votes and 1,000,000-share incentive plan - Stock Titan

Apr 21, 2026

Lipocine Reshapes Board Leadership Amid Strategic Shift - TipRanks

Apr 21, 2026

Board reshuffle at Lipocine (NASDAQ: LPCN) as chairman exits, new independent leader named - Stock Titan

Apr 21, 2026

What's going on with Lipocine stock on Monday? - MSN

Apr 21, 2026

Apr 18, 2026

Lipocine (LPCN) Stock: Investment Opportunity (Trend Weakens) 2026-04-18Pro Trader Recommendations - Xã Thanh Hà

Apr 18, 2026

Apr 13, 2026

A. G. P. Maintains Lipocine(LPCN.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Apr 13, 2026

Quarterly Risk: What is the Moat Score of Lipocine IncMarket Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn

Apr 13, 2026

Apr 11, 2026

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Apr 11, 2026

Apr 09, 2026

Is Lipocine (LPCN) Stock heavily shorted | Price at $2.03, Down 4.88%Catalyst Driven Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Apr 09, 2026

Apr 07, 2026

Higuchi John W. buys Lipocine (LPCN) shares worth $81199 - Investing.com UK

Apr 07, 2026

Higuchi John W. buys Lipocine (LPCN) shares worth $81199 By Investing.com - Investing.com India

Apr 07, 2026

Director John Higuchi adds 40,000 Lipocine (LPCN) shares at $2.03 - Stock Titan

Apr 07, 2026

Lipocine (NASDAQ:LPCN) CEO Mahesh Patel Acquires 25,000 Shares of Stock - Defense World

Apr 07, 2026

Apr 06, 2026

CEO Mahesh Patel Increases Stake in Lipocine Inc with Recent Sha - GuruFocus

Apr 06, 2026

Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 By Investing.com - Investing.com Australia

Apr 06, 2026

Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 - Investing.com

Apr 06, 2026

Director John W. Higuchi buys 123K Lipocine (LPCN) shares at $2.05 - Stock Titan

Apr 06, 2026

Lipocine CEO Patel acquires $50,749 in LPCN stock - Investing.com UK

Apr 06, 2026

Lipocine CEO Patel acquires $50,749 in LPCN stock By Investing.com - Investing.com India

Apr 06, 2026

Lipocine (LPCN) CEO adds 25,000 shares in stock purchase - Stock Titan

Apr 06, 2026

Lipocine adds to PPD setbacks as Tepezza scores, batoclimab misses in TED - BioCentury

Apr 06, 2026

LPCN Downgraded to Neutral by HC Wainwright & Co. | LPCN Stock N - GuruFocus

Apr 06, 2026

Finanzdaten der Lipocine Inc-Aktie (LPCN)

Umsatz

Nettogewinn

Free Cashflow

ENV

ROIV

$28.32

0.14%

RPRX

$50.44

0.48%

BNTX

$95.50

3.88%

INSM

$139.44

0.41%

RVMD

$147.21

0.47%

ONC

$297.49

0.12%

Lipocine Inc (LPCN)

Lipocine Inc Stock (LPCN) Company Profile

Compare LPCN vs VRTX, REGN, ARGX, ALNY, ONC

Lipocine Inc Stock (LPCN) Upgrades & Downgrades

Lipocine Inc Aktie (LPCN) Neueste Nachrichten

MSN Money - MSN

Lipocine Inc expected to post a loss of 48 cents a shareEarnings Preview - TradingView

Lipocine stock plunges after LPCN 1154 misses phase 3 primary endpoint - MSN

LPCN stock crashes 78%—here’s why - MSN

Lipocine (LPCN) price target decreased by 45.45% to 6.12 - MSN

Lipocine Announces Publication and Discussion of LPCN 1148 Manuscript at The Liver Meeting 2024 Editor's Cut Session - Quantisnow

Lipocine (LPCN) price target decreased by 15.38% to 11.22 - MSN

LPCN (Lipocine Inc.) posts narrower Q4 2025 loss than analyst estimates, shares rise modestly in trading today.Put/Call Ratio - Cổng thông tin điện tử tỉnh Tây Ninh

Lipocine (LPCN) 2026 proxy seeks director votes and 1,000,000-share incentive plan - Stock Titan

Lipocine Reshapes Board Leadership Amid Strategic Shift - TipRanks

Board reshuffle at Lipocine (NASDAQ: LPCN) as chairman exits, new independent leader named - Stock Titan

What's going on with Lipocine stock on Monday? - MSN

Lipocine (LPCN) Stock: Investment Opportunity (Trend Weakens) 2026-04-18Pro Trader Recommendations - Xã Thanh Hà

A. G. P. Maintains Lipocine(LPCN.US) With Buy Rating, Cuts Target Price to $6 - Moomoo

Quarterly Risk: What is the Moat Score of Lipocine IncMarket Growth Summary & Technical Buy Zone Confirmation - baoquankhu1.vn

Form 10-QQuarterly report [Sections 13 or 15(d)] - ADVFN

Is Lipocine (LPCN) Stock heavily shorted | Price at $2.03, Down 4.88%Catalyst Driven Stocks - Cổng thông tin điện tử Tỉnh Sơn La

Higuchi John W. buys Lipocine (LPCN) shares worth $81199 - Investing.com UK

Higuchi John W. buys Lipocine (LPCN) shares worth $81199 By Investing.com - Investing.com India

Director John Higuchi adds 40,000 Lipocine (LPCN) shares at $2.03 - Stock Titan

Lipocine (NASDAQ:LPCN) CEO Mahesh Patel Acquires 25,000 Shares of Stock - Defense World

CEO Mahesh Patel Increases Stake in Lipocine Inc with Recent Sha - GuruFocus

Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 By Investing.com - Investing.com Australia

Higuchi John W. buys Lipocine (LPCN) shares worth $252,149 - Investing.com

Director John W. Higuchi buys 123K Lipocine (LPCN) shares at $2.05 - Stock Titan

Lipocine CEO Patel acquires $50,749 in LPCN stock - Investing.com UK

Lipocine CEO Patel acquires $50,749 in LPCN stock By Investing.com - Investing.com India

Lipocine (LPCN) CEO adds 25,000 shares in stock purchase - Stock Titan

Lipocine adds to PPD setbacks as Tepezza scores, batoclimab misses in TED - BioCentury

LPCN Downgraded to Neutral by HC Wainwright & Co. | LPCN Stock N - GuruFocus

Finanzdaten der Lipocine Inc-Aktie (LPCN)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie LPCN